PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
February 16, 2012 | ISSUE NUMBER 237 VOL 8

Technology
Back to the Future: Can Sanofi Enhance R&D Productivity?
Sanofi Pasteur's vaccine division has developed a novel imitative, in vitro test and assay technology that can predict the immune response of a human individual or group to a vaccine candidate. But can it exploit the cost efficiencies to create a competitive advantage? ...Read More

Leadership
Guido Rasi's EMA Challenge
Guido Rasi, who took over as executive director of the European Medicines Agency last November, has many challenges ahead of him. And one of them is escaping from under the shadow cast by his predecessor. Rasi has shown some lithe thinking about squaring some of the circles he is confronted with. He has admitted there are problems, and has publicly promised "not to hide from them."
...Read More

Biotech
Shrinking Economy Hits California Biosector
A report released last week by the California Healthcare Institute, BayBio, and PwC details how the shrinking economy, changes in investment strategies, and pressures on the pharmaceutical market have put the brakes on one of the U.S.'s most robust biotechnology centers. ...Read More

Compliance
Europe Basking in the 'Sunshine'
The provisions in the Affordable Care Act have been illuminating issues around the financial interests of physicians and academics stateside. And now those same issues are breaking through the clouds across the Atlantic. Cegedim's second annual report on aggregate spend investigates how European countries are responding to Sunshine-type measures. ...Read more

Advertisement

Ad Stars 2012
Call for Entries
It's that time again for the editors of Pharm Exec to narrow down its choices for our annual Ad Stars feature, recognizing the most clever, unique, and effective campaigns in pharma advertising over the past year. We'd like to extend an opportunity for you to submit an ad for consideration. Please feel free to share with us the campaign that your firm or agency feels truly helps the client stand apart from its competition ...For more information

// Shire (Philadelphia) has appointed Gwen Fisher as Senior Corporate Communications Director for Specialty Pharma, where she will lead external and internal communications globally. // Stanford University professor David Mangus (PhD) and Summer Johnson McGee (PhD) of Loyola University Chicago will take over as co-Editors-in-Chief of the American Journal of Bioethics, effective March 1. The two take over from founding editor Glenn Edwards McGee. // Milton Boyer has been named President of OSO BioPharmaceuticals Manufacturing (Albuquerque, NM) and will also join the company’s Board of Directors. // Lycera (Ann Arbor, MI) announced that Steven Gillis, PhD, Managing Director of Arch Venture Partners, has been appointed Chairman of the Board. Michael Steinmetz, PhD, Managing Director of Clarus Ventures, has also joined Lycera’s Board.
// AbelsonTaylor (Chicago) promoted Casey Lewis to Senior Producer and hired Kathleen Kirk as Interactive Producer.// Claire Pisano, Senior Account Executive at Ogilvy CommonHealth Payer Marketing (Parsippany, N.J.) was inducted into the inaugural Future Famer's Program of the Medical Advertising Hall of Fame.// Diversinet has formally appointed Dr. Hon Pak as the company's Chief Executive Officer, having served in an interim capacity since December 2011. He was also named to the company's Board of Directors.// Seth Houston joined OpenQ as Vice President of Strategic Alliances, responsible for leading the company's channel strategy.

Feb. 28–29: Global Transparency Congress
London, UK


Feb. 28–29: 7th Forum on Medical Device and Diagnostics Reimbursement Strategies
San Diego, CA


March 5–6: 7th Summit on Biosimilars and Follow-On Biologics
Washington, D.C.


March 6–7: 13th Annual Patient Assistance and Access Programs
Baltimore, Maryland.



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook


Advertisement



Survey
To which of the following areas have you made changes to meet the challenge of demonstrating value?

Click To Vote
 
Quick Links

Patient Recruitment via Social Media: Lessons Learned

Talkback from Tufts: Defending R&D Costs

Sales Force Survey: Still Too Much Business as Usual?


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive